GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » 5-Year EBITDA Growth Rate

Alpa Laboratories (NSE:ALPA) 5-Year EBITDA Growth Rate : 25.90% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories 5-Year EBITDA Growth Rate?

Alpa Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹2.88.

During the past 12 months, Alpa Laboratories's average EBITDA Per Share Growth Rate was 109.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 41.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 25.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alpa Laboratories was 55.50% per year. The lowest was -20.50% per year. And the median was 19.10% per year.


Competitive Comparison of Alpa Laboratories's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's 5-Year EBITDA Growth Rate falls into.



Alpa Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Alpa Laboratories  (NSE:ALPA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Alpa Laboratories 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (NSE:ALPA) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.